Evidence map›Paper›PMID 31807815›Full record

ReviewCellular and molecular life sciences : CMLS2020

Stem cell-derived kidney organoids: engineering the vasculature.

Marije Koning, Cathelijne W van den Berg, Ton J Rabelink

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. FromLab on a chip · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Fabrication of functional ameloblasts from hiPSCs for dental application.Frontiers in cell and developmental biology · 2023
    Article
  19. Stem cells for organoids.Smart medicine · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marije KoningDepartment of Internal Medicine-Nephrology, Leiden University Medical Center, Leiden, The Netherlands. m.koning@lumc.nl.ORCID http://orcid.org/0000-0001-9094-1004
Cathelijne W van den BergDepartment of Internal Medicine-Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Ton J RabelinkDepartment of Internal Medicine-Nephrology, Leiden University Medical Center, Leiden, The Netherlands.

Funding

Bontius Stichting Wiyadharma fellowshipNierstichting RECORD KID 15RN02
6 · The paper itself

Abstract

Kidney organoids can be generated from human pluripotent stem cells (PSCs) using protocols that resemble the embryonic development of the kidney. The renal structures thus generated offer great potential for disease modeling, drug screening, and possibly future therapeutic application. At the same time, use of these PSC-derived organoids is hampered by lack of maturation and off-target differentiation. Here, we review the main protocols for the generation of kidney organoids from human-induced PSCs, discussing their advantages and limitations. In particular, we will focus on the vascularization of the kidney organoids, which appears to be one of the critical factors to achieve maturation and functionality of the organoids.

Indexed as

AnimalsCell Culture TechniquesCell DifferentiationHumansKidneyOrganoidsPluripotent Stem CellsAngiogenesisEndothelial cellsNephronsTransplantationVasculogenesis

Identifiers

PMID31807815
PMCPMC7275011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.